The Chemicals industry as a whole closed the day down 1.6% versus the S&P 500, which was down 1.0%. Laggards within the Chemicals industry included

Ikonics

(

IKNX

), down 1.9%,

Metabolix

(

MBLX

), down 10.8%,

NL Industries

(

NL

), down 6.2%,

Flexible Solutions International

(

FSI

), down 4.6% and

Valhi

(

VHI

), down 1.9%.

TheStreet Ratings Group would like to highlight 3 stocks that pushed the industry lower today:

Flexible Solutions International

(

FSI

) is one of the companies that pushed the Chemicals industry lower today. Flexible Solutions International was down $0.05 (4.6%) to $1.03 on light volume. Throughout the day, 21,626 shares of Flexible Solutions International exchanged hands as compared to its average daily volume of 180,000 shares. The stock ranged in price between $1.01-$1.09 after having opened the day at $1.08 as compared to the previous trading day's close of $1.08.

Flexible Solutions International, Inc., together with its subsidiaries, develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Flexible Solutions International has a market cap of $13.6 million and is part of the basic materials sector. Shares are down 4.7% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Flexible Solutions International a buy, 1 analyst rates it a sell, and none rate it a hold.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreet Ratings rates

Flexible Solutions International

as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself.

Highlights from TheStreet Ratings analysis on FSI go as follows:

  • The revenue growth greatly exceeded the industry average of 10.9%. Since the same quarter one year prior, revenues rose by 30.2%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
  • FSI's debt-to-equity ratio is very low at 0.16 and is currently below that of the industry average, implying that there has been very successful management of debt levels. To add to this, FSI has a quick ratio of 1.72, which demonstrates the ability of the company to cover short-term liquidity needs.
  • FLEXIBLE SOLUTIONS INTL INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, FLEXIBLE SOLUTIONS INTL INC reported lower earnings of $0.03 versus $0.14 in the prior year. This year, the market expects an improvement in earnings ($0.10 versus $0.03).
  • FSI has underperformed the S&P 500 Index, declining 11.02% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
  • Current return on equity is lower than its ROE from the same quarter one year prior. This is a clear sign of weakness within the company. In comparison to the other companies in the Chemicals industry and the overall market, FLEXIBLE SOLUTIONS INTL INC's return on equity is significantly below that of the industry average and is below that of the S&P 500.

You can view the full analysis from the report here:

Flexible Solutions International Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

At the close,

NL Industries

(

NL

) was down $0.31 (6.2%) to $4.73 on average volume. Throughout the day, 23,439 shares of NL Industries exchanged hands as compared to its average daily volume of 25,000 shares. The stock ranged in price between $4.60-$5.00 after having opened the day at $4.95 as compared to the previous trading day's close of $5.04.

NL Industries, Inc., through its subsidiary, CompX International Inc., operates in the component products industry in the United States and internationally. NL Industries has a market cap of $295.5 million and is part of the basic materials sector. Shares are down 41.4% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate NL Industries a buy, 1 analyst rates it a sell, and none rate it a hold.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreet Ratings rates

NL Industries

as a

hold

. Among the primary strengths of the company is its revenue growth. At the same time, however, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and poor profit margins.

Highlights from TheStreet Ratings analysis on NL go as follows:

  • The revenue growth came in higher than the industry average of 5.2%. Since the same quarter one year prior, revenues slightly increased by 7.6%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • NL INDUSTRIES has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, NL INDUSTRIES turned its bottom line around by earning $0.59 versus -$1.13 in the prior year. This year, the market expects an improvement in earnings ($0.73 versus $0.59).
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Commercial Services & Supplies industry. The net income has significantly decreased by 633.6% when compared to the same quarter one year ago, falling from $5.47 million to -$29.20 million.
  • The gross profit margin for NL INDUSTRIES is currently lower than what is desirable, coming in at 31.49%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -101.03% is significantly below that of the industry average.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 32.03%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 645.45% compared to the year-earlier quarter. Despite the heavy decline in its share price, this stock is still more expensive (when compared to its current earnings) than most other companies in its industry.

You can view the full analysis from the report here:

NL Industries Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Metabolix

(

MBLX

) was another company that pushed the Chemicals industry lower today. Metabolix was down $0.34 (10.8%) to $2.81 on light volume. Throughout the day, 9,300 shares of Metabolix exchanged hands as compared to its average daily volume of 18,900 shares. The stock ranged in price between $2.76-$3.08 after having opened the day at $3.08 as compared to the previous trading day's close of $3.15.

Metabolix, Inc., an advanced biomaterials company, focuses on delivering sustainable solutions to the plastics industry. The company develops and commercializes technologies for the production of polymers and chemicals in microbes and plants. Metabolix has a market cap of $69.1 million and is part of the basic materials sector. Shares are up 27.6% year-to-date as of the close of trading on Monday. Currently there are no analysts who rate Metabolix a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates

Metabolix

as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Highlights from TheStreet Ratings analysis on MBLX go as follows:

  • MBLX has underperformed the S&P 500 Index, declining 7.58% from its price level of one year ago. The fact that the stock is now selling for less than others in its industry in relation to its current earnings is not reason enough to justify a buy rating at this time.
  • The company's current return on equity greatly increased when compared to its ROE from the same quarter one year prior. This is a signal of significant strength within the corporation. Compared to other companies in the Chemicals industry and the overall market, METABOLIX INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has increased to -$6.66 million or 25.69% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of -16.05%.
  • MBLX has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 4.41, which clearly demonstrates the ability to cover short-term cash needs.
  • METABOLIX INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, METABOLIX INC continued to lose money by earning -$3.48 versus -$5.34 in the prior year. This year, the market expects an improvement in earnings (-$0.96 versus -$3.48).

You can view the full analysis from the report here:

Metabolix Ratings Report

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.